Long-term recurrence risk after a first venous thromboembolism in men and women under 50 years old: A French prospective cohort.

European Journal of Internal Medicine
Claire de MoreuilFrancis Couturaud

Abstract

Data on long-term venous thromboembolism (VTE) recurrence risk according to gender are conflicting. To evaluate long-term VTE recurrence risk after a first VTE in men and women under 50 years old. Since May 2000, 875 consecutive patients (315 men, 560 women) with a first symptomatic VTE under 50 years old were enrolled in a French prospective multicentre cohort study and were followed up as long as possible. The primary outcome was symptomatic recurrent VTE during follow-up. At baseline, men were older and had more comorbidities than women. First VTE was mainly unprovoked in men (80.6%) and hormone-related in women (84.3%). During a median follow-up of 7.0 years (inter-quartile range, 5.0-11.0), recurrent VTE occurred in 97 men (30.8%) and in 72 women (12.9%) (annual incidence rates of recurrent VTE of 4.8% versus 1.8%-person-years, P<0.001). However, there was no difference according to gender in subgroups of patients with a first unprovoked VTE (5.8% versus 3.8%-person-years, P = 0.09). In women, duration of hormonal treatment before first VTE did not influence recurrence risk. In multivariable analysis, unprovoked VTE and family history of VTE were independently associated with recurrence (hazard ratio of 2.50 (95% confidenc...Continue Reading

References

Mar 29, 2000·Archives of Internal Medicine·P O HanssonH Eriksson
Jun 18, 2004·The New England Journal of Medicine·Paul A KyrleSabine Eichinger
Dec 23, 2004·Journal of Thrombosis and Haemostasis : JTH·T BaglinC Baglin
Nov 19, 2005·Pathophysiology of Haemostasis and Thrombosis·María-José García-FusterLuis Maldonado
Jan 25, 2006·The American Journal of Medicine·Gregor HronPaul Alexander Kyrle
Jul 28, 2006·Journal of Thrombosis and Haemostasis : JTH·M CushmanP M Ridker
Jan 30, 2009·Journal of Thrombosis and Haemostasis : JTH·S R KahnUNKNOWN Subcommittee on Control of Anticoagulation of the Scientific and Standardization Committee of the International Society on T
Aug 27, 2010·Journal of Thrombosis and Haemostasis : JTH·S C ChristiansenS C Cannegieter
Mar 26, 2011·Thrombosis Research·Marianne S AndresenUlrich Abildgaard
Nov 22, 2011·Thrombosis Research·Valérie OliéJoseph Emmerich
Nov 2, 2012·Journal of Thrombosis and Haemostasis : JTH·K GauthierUNKNOWN REVERSE investigators
Jul 8, 2015·JAMA : the Journal of the American Medical Association·Francis CouturaudUNKNOWN PADIS-PE Investigators
Oct 4, 2016·Journal of Thrombosis and Haemostasis : JTH·P A KyrleS Eichinger
Jul 29, 2017·The European Respiratory Journal·Raphael Le MaoFrancis Couturaud
Jan 6, 2018·The European Respiratory Journal·Cécile TromeurUNKNOWN PADIS-PE Investigators18
Mar 20, 2018·European Journal of Internal Medicine·L M MollardK Lacut

❮ Previous
Next ❯

Citations

Jan 10, 2021·European Journal of Internal Medicine·Sabine Eichinger, Paul A Kyrle

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.